(Q48070488)

English

Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

0 references

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Esther C van den Broek

1

object named as

Esther C van den Broek

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

author name string

Simone Oerlemans

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Marten R Nijziel

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Eduardus F M Posthuma

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Jan Willem W Coebergh

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Lonneke V van de Poll-Franse

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

publication date

20 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

94

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

45-56

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Treatment of elderly patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Therapy of elderly/comorbid patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Refinement and psychometric evaluation of the impact of cancer scale.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Assessing the impact of cancer: development of a new instrument for long-term survivors

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2161-6

21 January 2018

Identifiers

10.1007/S00277-014-2161-6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/25038918

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48070488&oldid=2246172733"